Skip to main content
Top
Published in: Neurocritical Care 3/2013

01-06-2013 | Original Article

Clinical Outcomes Following Prolonged Refractory Status Epilepticus (PRSE)

Authors: R. D. Kilbride, A. S. Reynolds, J. P. Szaflarski, L. J. Hirsch

Published in: Neurocritical Care | Issue 3/2013

Login to get access

Abstract

Background

To define the clinical profile and outcome of patients in prolonged refractory status epilepticus (PRSE), and investigate possible predictors of outcome.

Methods

We reviewed 63 consecutive patients with PRSE cared for in the medical and neurointensive care units of three academic medical centers over a 9-year period. For this multi-center retrospective cohort study, PRSE was defined as SE that persisted despite at least 1 week of induced coma. Variables examined for their relationship to outcome included etiology, EEG, neuroimaging, and age.

Results

Forty-two (66 %) of 63 patients in PRSE survived to discharge from hospitalization. Fourteen (22 %) patients had a good outcome (mRS ≤ 3) at last available follow up (at least 6 months post-PRSE). Of these, 6 (10 %) individuals had no significant disability and were able to carry out all usual activities (mRS = 1). Normal neuroimaging and a reactive EEG at onset of PRSE were associated with good outcome. Good or excellent clinical outcomes were possible in patients in PRSE for up to 79 days, and in patients up to 69 years old.

Conclusions

Good outcome is not unusual in PRSE, including in some older patients, in a variety of diagnoses, and despite months of coma.
Literature
1.
go back to reference Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205–10.PubMedCrossRef Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol. 2002;59(2):205–10.PubMedCrossRef
2.
go back to reference DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35.PubMedCrossRef DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35.PubMedCrossRef
5.
go back to reference Drislane FW, Lopez MR, Blum AS, Schomer DL. Survivors and nonsurvivors of very prolonged status epilepticus. Epilepsy Behav. 2011;22(2):342–5.PubMedCrossRef Drislane FW, Lopez MR, Blum AS, Schomer DL. Survivors and nonsurvivors of very prolonged status epilepticus. Epilepsy Behav. 2011;22(2):342–5.PubMedCrossRef
6.
go back to reference Bramstedt KA, Morris HH, Tanner A. Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus. Epilepsy Behav. 2004;5(5):752–5.PubMedCrossRef Bramstedt KA, Morris HH, Tanner A. Now we lay them down to sleep: ethical issues with the use of pharmacologic coma for adult status epilepticus. Epilepsy Behav. 2004;5(5):752–5.PubMedCrossRef
7.
go back to reference van Swieten J, Koudstaal P, Visser M, Schouten H, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7.PubMedCrossRef van Swieten J, Koudstaal P, Visser M, Schouten H, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7.PubMedCrossRef
8.
go back to reference Young GB, Kreeft JH, McLachlan RS, et al. EEG and clinical associations with mortality in comatose patients in a general intensive care unit. J Clin Neurophysiol. 1999;16:354–60.PubMedCrossRef Young GB, Kreeft JH, McLachlan RS, et al. EEG and clinical associations with mortality in comatose patients in a general intensive care unit. J Clin Neurophysiol. 1999;16:354–60.PubMedCrossRef
9.
go back to reference Austin EJ, Wilkus RJ, Longstreth WT Jr. Etiology and prognosis of alpha coma. Neurology. 1988;38:773–7.PubMedCrossRef Austin EJ, Wilkus RJ, Longstreth WT Jr. Etiology and prognosis of alpha coma. Neurology. 1988;38:773–7.PubMedCrossRef
10.
go back to reference Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980;69(5):657–66.PubMedCrossRef Aminoff MJ, Simon RP. Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med. 1980;69(5):657–66.PubMedCrossRef
11.
go back to reference Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H. A “malignant” variant of status epilepticus. Arch Neurol. 2005;62:1428–31.PubMedCrossRef Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord H. A “malignant” variant of status epilepticus. Arch Neurol. 2005;62:1428–31.PubMedCrossRef
Metadata
Title
Clinical Outcomes Following Prolonged Refractory Status Epilepticus (PRSE)
Authors
R. D. Kilbride
A. S. Reynolds
J. P. Szaflarski
L. J. Hirsch
Publication date
01-06-2013
Publisher
Humana Press Inc
Published in
Neurocritical Care / Issue 3/2013
Print ISSN: 1541-6933
Electronic ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-013-9823-4

Other articles of this Issue 3/2013

Neurocritical Care 3/2013 Go to the issue